Cite
Chuong MD, Frakes JM, Figura N, et al. Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. J Gastrointest Oncol. 2016;7(2):221-7doi: 10.3978/j.issn.2078-6891.2015.075.
Chuong, M. D., Frakes, J. M., Figura, N., Hoffe, S. E., Shridhar, R., Mellon, E. A., Hodul, P. J., Malafa, M. P., Springett, G. M., & Centeno, B. A. (2016). Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. Journal of gastrointestinal oncology, 7(2), 221-7. https://doi.org/10.3978/j.issn.2078-6891.2015.075
Chuong, Michael D, et al. "Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer." Journal of gastrointestinal oncology vol. 7,2 (2016): 221-7. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.075
Chuong MD, Frakes JM, Figura N, Hoffe SE, Shridhar R, Mellon EA, Hodul PJ, Malafa MP, Springett GM, Centeno BA. Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. J Gastrointest Oncol. 2016 Apr;7(2):221-7. doi: 10.3978/j.issn.2078-6891.2015.075. PMID: 27034789; PMCID: PMC4783738.
Copy
Download .nbib